Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma: a single-arm phase 2 trial.
Cao X, Huang HY, Liang CX, Lin ZC, Zhou JY, Chen X, Huang YY, Zhan ZJ, Ke LR, Han LJ, Xia WX, Tang LQ, Guo SS, Liang H, Guo X, Lv X.
Cao X, et al. Among authors: han lj.
Nat Commun. 2024 Jan 31;15(1):949. doi: 10.1038/s41467-024-45276-1.
Nat Commun. 2024.
PMID: 38297016
Free PMC article.
Clinical Trial.